Board Meeting

ZYDUS LIFESCIENCES LTD.

NSE : ZYDUSLIFEBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE1011.7512.15 (+1.22 %)
PREV CLOSE ( ) 999.60
OPEN PRICE ( ) 998.85
BID PRICE (QTY) 1011.00 (1)
OFFER PRICE (QTY) 1011.25 (18)
VOLUME 40426
TODAY'S LOW / HIGH ( )987.00 1020.95
52 WK LOW / HIGH ( )478.45 1030.15
NSE1016.8517.15 (+1.72 %)
PREV CLOSE( ) 999.70
OPEN PRICE ( ) 993.00
BID PRICE (QTY) 1017.50 (7)
OFFER PRICE (QTY) 1017.70 (2)
VOLUME 1157070
TODAY'S LOW / HIGH( ) 986.30 1021.00
52 WK LOW / HIGH ( )478.2 1027.8

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.